TRVI - Trevi Therapeutics Inc. (TRVI) CEO Jennifer Good on Q3 2021 Results - Earnings Call Transcript

Trevi Therapeutics, Inc. (TRVI) Q3 2021 Earnings Conference Call November 10, 2021, 04:30 PM ET Company Participants Jennifer Good - President and CEO Bill Forbes - Chief Development Officer Lisa Delfini - CFO Conference Call Participants Nick Rubino - Stifel Rohit Bhasin - Needham & Company Presentation Operator Good afternoon, and welcome to the Trevi Therapeutics Third Quarter 2021 Earnings Conference Call. At this time, all participants will be in listen-only mode. [Operator Instructions] Please note this event may be recorded. Various remarks the management makes during this call about the company's future expectations, plans, and prospects constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of the company's most recent quarterly report

For further details see:

Trevi Therapeutics, Inc. (TRVI) CEO Jennifer Good on Q3 2021 Results - Earnings Call Transcript